Top Page
Audeara Ltd.
(Sydney:AUA)
Audeara Ltd. (AUA) vs. iShares MSCI Australia ETF (EWA)
Audeara Ltd. Business Overview & Revenue Model
Audeara Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.79M | 3.79M | 3.19M | 2.91M | 2.07M | 1.12M |
| Gross Profit | 1.36M | 1.36M | 943.12K | 1.14M | 946.11K | 510.33K |
| EBITDA | -2.90M | -2.90M | -2.75M | -3.80M | -3.07M | -1.08M |
| Net Income | -1.79M | -1.79M | -1.60M | -3.74M | -2.95M | -1.25M |
Balance Sheet | ||||||
| Total Assets | 4.30M | 4.30M | 4.89M | 4.73M | 5.49M | 6.57M |
| Cash, Cash Equivalents and Short-Term Investments | 1.42M | 1.42M | 1.27M | 2.62M | 2.87M | 5.74M |
| Total Debt | 1.12M | 1.12M | 112.18K | 210.74K | 275.11K | 67.60K |
| Total Liabilities | 3.01M | 3.01M | 3.28M | 1.57M | 1.41M | 665.76K |
| Stockholders Equity | 1.29M | 1.29M | 1.61M | 3.17M | 4.08M | 5.91M |
Cash Flow | ||||||
| Free Cash Flow | -1.95M | -1.95M | -1.34M | -2.98M | -3.78M | -1.11M |
| Operating Cash Flow | -1.81M | -1.81M | -1.33M | -2.97M | -3.58M | -1.08M |
| Investing Cash Flow | -149.02K | -149.02K | -8.47K | -16.00K | -229.26K | -23.71K |
| Financing Cash Flow | 2.08M | 2.08M | -10.88K | 2.74M | 939.73K | 7.10M |
Audeara Ltd. Technical Analysis
Audeara Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | AU$13.57M | -6.38 | -123.13% | ― | 18.86% | -14.41% | |
48 Neutral | AU$15.46M | -1.37 | -684.77% | ― | 8.64% | 33.88% | |
44 Neutral | AU$13.40M | -0.99 | -135.89% | ― | -21.60% | -657.00% | |
41 Neutral | AU$8.11M | -0.32 | ― | ― | -51.64% | -21.74% | |
37 Underperform | AU$181.10M | -14.84 | ― | ― | -100.00% | 44.26% |
Audeara Ltd. Corporate Events
Audeara reported Q2 FY26 unaudited group revenue of $1.43 million, flat on the prior quarter but 274% higher than the same period a year earlier, supported by strong wholesale and technology licensing sales. Combined Q1 and Q2 FY26 revenues, together with a secured $560,000 purchase order to be recognised in Q3, now exceed $3.5 million, bringing the company close to its full FY25 revenue of $3.8 million, while the quarter delivered positive net operating cash flow of $356,000, boosted by a $1.22 million R&D tax refund, leaving $0.74 million in cash at bank at 31 December 2025. Operationally, momentum was underpinned by National Medical Products Administration certification in China for a hearing aid product, enabling commercial launch and a maiden licensing order from Eastech, a chip-level AI licensing deal with China-based SoC designer OPTEK Microelectronics, and a distribution agreement with Tokyo-based Eyear System to introduce Auracast-enabled products into Japan, collectively strengthening Audeara’s Asia-Pacific footprint and supporting its push toward recurring global licensing income and more consistent operational cash flow.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited announced a clarification regarding its recent chip-level AI licensing agreement with Optek Microelectronics Co., Ltd. The agreement involves licensing Audeara’s proprietary AI audio algorithms and other audio technologies, but the company confirmed that no revenue has been generated from this deal to date, nor is its financial impact currently predictable. While the agreement lacks a definitive term, Audeara views it as an opportunity to explore further collaborations with Optek. The development reflects the company’s ongoing commitment to leveraging its audio innovations within the global market.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Ltd. has secured a significant chip-level AI audio licensing agreement with Optek Microelectronics, a leading SoC design company in China. This deal allows Audeara’s proprietary audio processing algorithms to be integrated into Optek’s SoC platforms, expanding Audeara’s market reach by embedding its technology at the silicon level in global product platforms. The agreement is expected to be revenue-generative for Audeara on a fee-per-chip basis, enhancing its industry positioning and supporting its strategy to expand the adoption of its algorithms across global OEM and ODM partners.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Ltd. announced a record $560,000 purchase order from a major Australian wholesale customer, marking the largest single order to date for the company. This order boosts the company’s year-to-date Australian wholesale revenues to approximately $1.75 million, a 50% increase over the previous year. The company is also advancing its AUA Technology division, with ongoing negotiations for additional orders from global markets and the commencement of manufacturing hearing aids for the Chinese market. These developments underscore Audeara’s strengthening position in the hearing technology sector and its strategic focus on multi-channel growth through licensing and distribution partnerships.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited has announced a change in the director’s interest, specifically regarding David Trimboli’s holdings. The change involves the acquisition of 954,763 ordinary fully paid shares and 1,250,000 unlisted options, which were issued as part of director fees and incentive options approved at the recent AGM. This adjustment in holdings reflects a strategic move to align director interests with company performance and shareholder value, potentially impacting the company’s governance and stakeholder confidence.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited announced a change in the director’s interest notice, specifically regarding Hsin-Chieh ‘Bill’ Peng. The change involves the acquisition of 1,500,000 unlisted options expiring on December 2, 2027, at an estimated value of $25,395. This acquisition was approved as incentive options at the company’s AGM, reflecting strategic moves in director-level holdings which may influence stakeholder perceptions and company operations.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited has issued 954,763 shares at an issue price of $0.028, following approval at the recent Annual General Meeting. This move aligns with the company’s compliance with relevant corporate regulations and indicates no undisclosed information that could affect investor assessments. The issuance is part of Audeara’s ongoing efforts to strengthen its market position and enhance shareholder value.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Ltd. announced the issuance of 4,250,000 unlisted options, set to expire on December 2, 2027, with an exercise price of $0.05. This move is part of previously announced transactions and reflects the company’s strategic efforts to enhance its financial flexibility and operational capabilities, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited has secured NMPA certification for its hearing personalisation technology in China, marking a significant regulatory and commercial milestone. This achievement enables the company to launch its product in China’s high-growth hearing aid market, enhancing its strategic partnership with Eastech and supporting its global licensing and commercial expansion strategy.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited has received $1.22 million from the Australian Government’s R&D Tax Incentive for the 2025 financial year, which has significantly benefited the company’s development of state-of-the-art headphones and personal sound amplification solutions. This funding has allowed Audeara to repay its R&D loan facility, extend its cash runway, and accelerate progress with international partners, ultimately supporting its technology roadmap and preserving shareholder value.
Audeara Limited held its Annual General Meeting, where all resolutions, including the special resolutions for the approval of the 7.1A Mandate and the renewal of Proportional Takeover Provisions, were passed. This outcome reflects strong shareholder support and may positively impact the company’s strategic direction and governance, reinforcing its market position in the hearing health industry.